Skip to main content
. Author manuscript; available in PMC: 2011 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2010 Aug 5;248(2):156–164. doi: 10.1016/j.taap.2010.07.023

Figure 3.

Figure 3

MeHg induces increases in GFP fluorescence of gst-4::GFP (A), hsp-4::GFP (B), mtl-1::GFP (C) and mtl-2::GFP (D). After an acute treatment at the L1 stage, increases in fluorescence were observed in gst-4::GFP (A, p<0.01) and mtl-1::GFP (C, p<0.05) strains (n=5). Chronic treatment at the L4 stage induced in increases in fluorescence in gst-4::GFP (A, p<0.001) and hsp-4::GFP (B, p<0.05) strains (n=5).